We are live on ! Find out more
IGMS

IGM Biosciences
IGMS

Delisted

IGMS was delisted on the 13th of August, 2025.

Back to rankings

93 hedge funds and large institutions have $487M invested in IGM Biosciences in 2022 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 33 increasing their positions, 19 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more call options, than puts

Call options by funds: $15M | Put options by funds: $7.91M

74% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 19

29% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 21

7% more funds holding

Funds holding: 87 → 93 (+6)

2.34% more ownership

Funds ownership: 67.77% → 70.11% (+2.3%)

5% less capital invested

Capital invested by funds: $514M → $487M (-$26.9M)

Holders
93
Holders Change
+6
Holders Change %
+6.9%
% of All Funds
1.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
33
Reduced
19
Closed
21
Calls
$15M
Puts
$7.91M
Net Calls
+$7.11M
Net Calls Change
+$6.92M

Top Buyers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
+$9.31M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$7.73M
3
EC
EcoR1 Capital
California
+$5.56M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$4.72M
5
UBS AM
UBS AM
Illinois
+$3.72M

Top Sellers

Rank Fund Capital Flow
1
PAMS
Pictet Asset Management (Switzerland)
Switzerland
-$27.4M
2
State Street
State Street
Massachusetts
-$10.4M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$2.33M
4
EGP
Entrust Global Partners
New York
-$1.94M
5
CAM
Cormorant Asset Management
Massachusetts
-$1.82M
Name Holding Trade Value Shares
Change 		Change in
Stake
HF
26
HRT Financial
New York
$1.54M +$846K +45,424 +373%
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$1.5M -$37.6K -2,022 -3%
BC
28
Bruce & Co
Illinois
$1.47M – – –
Citadel Advisors
29
Citadel Advisors
Florida
$1.43M +$995K +53,432 New
Ensign Peak Advisors
30
Ensign Peak Advisors
Utah
$1.25M – – –
State of Wisconsin Investment Board
31
State of Wisconsin Investment Board
Wisconsin
$1.17M +$627K +33,700 +334%
RJA
32
Raymond James & Associates
Florida
$1.07M +$355K +19,067 +91%
GCP
33
GSA Capital Partners
United Kingdom
$976K +$537K +28,847 +376%
Squarepoint
34
Squarepoint
New York
$957K +$494K +26,543 +286%
EBA
35
Eagle Bay Advisors
New York
$931K – – –
TD Asset Management
36
TD Asset Management
Ontario, Canada
$870K -$325K -17,472 -35%
Manulife (Manufacturers Life Insurance)
37
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$814K +$585K +31,418 New
OQS
38
Occudo Quantitative Strategies
Florida
$733K +$510K +27,408 New
Bank of New York Mellon
39
Bank of New York Mellon
New York
$723K +$13.6K +728 +3%
HT
40
HAP Trading
New York
$610K +$425K +22,814 New
PP
41
PDT Partners
New York
$505K +$352K +18,909 New
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$497K -$319K -17,116 -48%
Swiss National Bank
43
Swiss National Bank
Switzerland
$495K +$27.9K +1,500 +9%
Two Sigma Investments
44
Two Sigma Investments
New York
$483K -$1.04M -55,825 -76%
N
45
Nuveen
North Carolina
$420K +$47.1K +2,530 +11%
AllianceBernstein
46
AllianceBernstein
Tennessee
$401K – – –
Tudor Investment Corp
47
Tudor Investment Corp
Connecticut
$391K +$273K +14,639 New
IA
48
IndexIQ Advisors
New York
$373K +$260K +13,971 New
PI
49
Putnam Investments
Massachusetts
$327K +$39.1K +2,102 +21%
JP Morgan Chase
50
JP Morgan Chase
New York
$312K +$76.6K +4,115 +55%
1
2
3 4 5

IGMS Hedge Fund Activity: Q1 2022 in Review

93 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in IGM Biosciences (IGMS) for Q1 2022, worth a combined $487M — down 5.2% from $514M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new IGMS positions and 21 closed out — a net gain of 6 holders — while 33 added to existing stakes and 19 trimmed.

The largest buyer was Artal Group, adding an estimated $9.31M. The largest seller was Pictet Asset Management (Switzerland), exiting entirely with an estimated $27.4M sold.

  • 93 institutional investors held IGM Biosciences (IGMS) as of Q1 2022, up from 87 in Q4 2021.
  • Funds reported $487M of IGM Biosciences stock for Q1 2022, down 5.2% quarter-over-quarter.
  • 27 funds opened new IGM Biosciences positions in Q1 2022 and 21 closed out, a net change of +6 holders.
  • The largest IGM Biosciences buyer in Q1 2022 was Artal Group, an estimated $9.31M added.
  • The largest IGM Biosciences seller in Q1 2022 was Pictet Asset Management (Switzerland), an estimated $27.4M sold.

Based on aggregated 13F filings for Q1 2022.